PWM
VYGR icon

Palumbo Wealth Management’s Voyager Therapeutics VYGR Stock Holding History

Palumbo Wealth Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Buy
64,247
+1,463
+2% +$5.55K 0.05% 218
2026
Q1 		$242K Buy
62,784
+24,297
+63% +$95.7K 0.06% 193
2025
Q4 		$151K Buy
+38,487
New +$170K 0.04% 214

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Palumbo Wealth Management's VYGR Position: Q2 2026 in Review

Palumbo Wealth Management increased its Voyager Therapeutics (VYGR) stake by 2.3% in Q2 2026, buying an estimated $5.55K and bringing the position to 64,247 shares worth $225K. The position accounts for 0.05% of the portfolio, ranked #218.

Palumbo Wealth Management first reported a position in VYGR in Q4 2025 and has held it in 3 quarters since. The position peaked at $242K in Q1 2026. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Palumbo Wealth Management held 64,247 shares of Voyager Therapeutics worth $225K as of Q2 2026.
  • Palumbo Wealth Management bought 1,463 Voyager Therapeutics shares in Q2 2026, an estimated $5.55K.
  • Voyager Therapeutics made up 0.05% of Palumbo Wealth Management's portfolio in Q2 2026, its #218 holding.
  • Palumbo Wealth Management first reported a position in Voyager Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Palumbo Wealth Management's Voyager Therapeutics position peaked at $242K in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.